Medical device company BioSig has inked a 10-year strategic partnership with Mayo Clinic and Mayo Clinic Ventures. The expanded par expanded collaboration with Mayo builds upon the work realized under the Advanced Clinical Research Program that was signed with Mayo Clinic in March 2016.Partnership DetailsAs part of 10-year agreement, BioSig and Mayo will be developing advanced clinical features and applications for the company’s PURE EP System, which is addressing an unmet technology need for
Read More
Mayo Clinic Health System | News, Analysis, Insights - HIT Consultant
Mayo Clinic, iSpecimen Collaborate on Cancer/Normal Serum Biobank
Mayo Clinic Center for Individualized Medicine has selected iSpecimen, a customized human biospecimen collections company to serve as the exclusive channel partner for the Mayo Clinic Cancer/Normal Serum Biobank, connecting biomedical researchers with the samples and associated data for their studies. Mayo Clinic Cancer/Normal Serum Biobank OverviewBased in Rochester, Minnesota, the Cancer/Normal Serum Biobank has approximately 130,000 frozen vials of serum from about 17,000 unique, consented
Read More
Mayo Clinic, Philips Partner on Mt. Kilimanjaro Climb for Cardiac Research
Philips is collaborating with the Mayo Clinic to climb Mount Kilimanjaro on a research expedition to understand how the body reacts to the rigors of high altitude and how those learnings can be applied to improving human health. Because the lack of oxygen at high altitudes mimics oxygen deprivation in the body during a cardiac event, Philips researchers hope to understand how to better detect and prevent cardiac issues. The expedition starts on August 7 and its expected to last approximately 10
Read More
ImpediMed, Mayo Clinic Partner to Explore Body Fluid Status Monitoring Tech
ImpediMed Ltd, a Australia-based medical device startup has signed a three-year joint development agreement with Mayo Clinic to explore uses for body fluid status monitoring technology. ImpediMed employs bioimpedance spectroscopy (BIS) technologies for use in the non-invasive clinical assessment and monitoring of fluid status in patients. ImpediMed has the first medical device with FDA clearance in the U.S. to aid healthcare professionals to clinically assess secondary unilateral lymphedema of
Read More
Mayo Clinic Makes Strategic Investment in Transplant Genomics
Transplant Genomics has announced a collaboration with the Mayo Clinic to develop, validate, and commercialize diagnostic tests enabling personalized immunosuppression for solid organ transplant recipients. As part of the multiyear collaboration, Mayo Clinic will make an investment in Transplant Genomics for an undisclosed amount. Additionally, both companies with work together on co-development of new tests and technologies for additional targets, including exploratory studies in heart and
Read More
Google, Mayo Clinic, Harvard Team Up for Easy Symptom Search
Roughly 1 percent of searches on Google are symptom related. Starting this week, when consumers access Google’s mobile search for information about certain symptoms, they will quick, accurate facts on relevant related medical conditions up front on their smartphone or other mobile device.Announced in a blog post by Veronica Pinchin, a product manager on Google's search team, the goal of the new symptom search feature allows consumers to quickly explore and navigate health conditions related to
Read More
Mayo Clinic, GE Set to Unveil Innovative Compact MRI Scanner
On June 28th, Mayo Clinic will unveil a new first of its kind compact 3T magnetic resonance imaging (MRI) scanner developed in collaboration with General Electric's (GE) Global Research Center. The investigational, research device was developed under a National Institutes of Health Bioengineering Research Partnership between GE Global Research and the Mayo Clinic.Compact 3T MRI Scanner OverviewThe new MRI scanner is designed specifically to perform head scans, as well as small extremities, such
Read More
NIH Awards Mayo Clinic $142M to Create Biobank for Precision Medicine Initiative
The National Institutes of Health (NIH) has awarded Mayo Clinic $142 million over five years as part of President Obama's Precision Medicine Initiative to create the world’s largest biobank for the PMI Cohort Program. Mayo Clinic will use the funding to support the collection, storage and distribution for research use of biological samples known as biospecimens. Laboratory analyses of the biospecimens, including chemical and genetic tests, will be a key component of the core PMI Cohort Program
Read More
Mayo Clinic Launches CQI Program to Minimize Complications from Retained Blood in Heart Surgery Patients
ClearFlow, a California-based company that develops technology to maximize post-operative blood evacuation after cardiac surgery and Mayo Clinic are launching research a Continuous Quality Improvement (CQI) program for patients recovering from heart surgery. Simon Maltais, MD, PhD, Mayo Clinic Associate Professor of Surgery, Division of Cardiovascular Surgery will serve as the Principal Investigator for the CQI program. Recent studies have demonstrated that up to 20% of patients recovering from
Read More
Mayo Clinic, GE Ventures Partner to Bring IoT Approach to Cell, Gene Therapies
Today, GE Ventures and Mayo Clinic announced they are teaming up to launch Vitruvian Networks, Inc., an independent platform company committed to accelerating access to cell and gene therapies through advanced, cloud-ready software systems and manufacturing services. Vitruvian Networks will partner with therapy producers and serve them by providing a state-of-the-art software and manufacturing platform to bring the Internet of Things (IoT) to cell and gene therapies. At scale, the platform will
Read More
